(Q90382740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

2 references

1 August 2020

19 November 2020

The expansion of targetable biomarkers for CAR T cell therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

main subject

adoptive immunotherapy

1 reference

1 August 2020

1 reference

19 November 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Richard Robison

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Kim L O'Neill

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

author name string

Gajendra Shrestha

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

publication date

21 July 2018

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 August 2020

19 November 2020

Journal of Experimental & Clinical Cancer Research

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 August 2020

19 November 2020

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 April 2020

copyright license

2 references

1 August 2020

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

19 November 2020

cites work

1 reference

12 December 2020

Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells.

1 reference

12 December 2020

Distribution of tumor-associated glycoprotein-72 (TAG-72) expression throughout the normal female reproductive tract

1 reference

12 December 2020

T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease

1 reference

12 December 2020

Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies

1 reference

12 December 2020

Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2

1 reference

12 December 2020

An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin.

1 reference

12 December 2020

The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins

1 reference

12 December 2020

A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas

1 reference

12 December 2020

Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer

1 reference

12 December 2020

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

1 reference

12 December 2020

Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levels

1 reference

12 December 2020

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells

1 reference

12 December 2020

Expression of normal myeloid-associated antigens by acute leukemia cells

1 reference

12 December 2020

Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions

1 reference

12 December 2020

Immunohistochemistry of Carcino-Embryonic Antigen in the Embryo, Fetus and Adult

1 reference

12 December 2020

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients

1 reference

12 December 2020

HPRT: gene structure, expression, and mutation

1 reference

12 December 2020

Prostate antigen: A new potential marker for prostatic cancer

1 reference

12 December 2020

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors

1 reference

12 December 2020

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2

1 reference

12 December 2020

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1 reference

12 December 2020

A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells

1 reference

12 December 2020

Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment.

1 reference

12 December 2020

TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49

1 reference

12 December 2020

In vitro evaluation of Pyrularia thionin-anti-CD5 immunotoxin

1 reference

12 December 2020

Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells

1 reference

12 December 2020

Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.

1 reference

12 December 2020

Protein tyrosine kinase expression during the estrous cycle and carcinogenesis of the mammary gland

1 reference

12 December 2020

Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction

1 reference

12 December 2020

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

1 reference

12 December 2020

The cloning of CD70 and its identification as the ligand for CD27

1 reference

12 December 2020

Characterization of the human CD27 ligand, a novel member of the TNF gene family.

1 reference

12 December 2020

Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis

1 reference

12 December 2020

Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients

1 reference

12 December 2020

CEA tissue staining in colorectal cancer patients--correlation with plasma CEA, histology and staging

1 reference

12 December 2020

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

1 reference

12 December 2020

Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation

1 reference

12 December 2020

Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors

1 reference

12 December 2020

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

1 reference

12 December 2020

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues

1 reference

12 December 2020

Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

1 reference

12 December 2020

Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy.

1 reference

12 December 2020

Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization

1 reference

12 December 2020

Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells

1 reference

12 December 2020

Stability of HPRT marker gene expression at different gene-targeted loci: observing and overcoming a position effect.

1 reference

12 December 2020

Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4(+) T cells in vivo

1 reference

12 December 2020

Selective expression of carcinoembryonic antigen promoter in cancer cell lines: targeting strategy for gene therapy in colorectal cancer

1 reference

12 December 2020

Serum and tissue CEA in colorectal cancer: clinical relevance.

1 reference

12 December 2020

Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product

1 reference

12 December 2020

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

1 reference

12 December 2020

Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells

1 reference

12 December 2020

Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells

1 reference

12 December 2020

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells

1 reference

12 December 2020

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

12 December 2020

Aberrant expression and reverse signalling of CD70 on malignant B cells

1 reference

12 December 2020

TAG-72 expression and clinical outcome in primary breast cancer

1 reference

12 December 2020

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors

1 reference

12 December 2020

An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas

1 reference

12 December 2020

The biology of the 17-1A antigen (Ep-CAM)

1 reference

12 December 2020

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

1 reference

12 December 2020

Mesothelin is not required for normal mouse development or reproduction

1 reference

12 December 2020

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

1 reference

12 December 2020

Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer

1 reference

12 December 2020

The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody

1 reference

12 December 2020

Immunohistochemical analysis of human CD5 positive B cells: mantle cells and mantle cell lymphoma are not equivalent in terms of CD5 expression

1 reference

12 December 2020

Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel

1 reference

12 December 2020

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

1 reference

12 December 2020

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

1 reference

12 December 2020

CD27 is required for generation and long-term maintenance of T cell immunity

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells

1 reference

12 December 2020

Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas

1 reference

12 December 2020

Glypicans: proteoglycans with a surprise

1 reference

12 December 2020

Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma

1 reference

12 December 2020

Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies

1 reference

12 December 2020

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

1 reference

12 December 2020

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

1 reference

12 December 2020

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck

1 reference

12 December 2020

Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma

1 reference

12 December 2020

Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.

1 reference

12 December 2020

Characterization of human blood dendritic cell subsets

1 reference

12 December 2020

Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors

1 reference

12 December 2020

Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse

1 reference

12 December 2020

Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors

1 reference

12 December 2020

Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients

1 reference

12 December 2020

Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain

1 reference

12 December 2020

Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers

1 reference

12 December 2020

Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.

1 reference

12 December 2020

Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer

1 reference

12 December 2020

Mesothelin: a new target for immunotherapy

1 reference

12 December 2020

Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer

1 reference

12 December 2020

Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer

1 reference

12 December 2020

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

1 reference

12 December 2020

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract

1 reference

12 December 2020

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

1 reference

12 December 2020

CD70: a new tumor specific biomarker for renal cell carcinoma

1 reference

12 December 2020

Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues

1 reference

12 December 2020

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.

1 reference

12 December 2020

Vascular endothelial growth factor receptors: expression and function in solid tumors

1 reference

12 December 2020

Vascular endothelial growth factors and receptors in colorectal cancer: Implications for anti-angiogenic therapy

1 reference

12 December 2020

Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas

1 reference

12 December 2020

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer

1 reference

12 December 2020

Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis.

1 reference

12 December 2020

Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy

1 reference

12 December 2020

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

1 reference

12 December 2020

CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding.

1 reference

12 December 2020

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer

1 reference

12 December 2020

Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities

1 reference

12 December 2020

Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.

1 reference

12 December 2020

CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy

1 reference

12 December 2020

CD38/CD19: a lipid raft-dependent signaling complex in human B cells

1 reference

12 December 2020

Mesothelin expression in human lung cancer

1 reference

12 December 2020

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection

1 reference

12 December 2020

Clinical implications of fibroblast activation protein in patients with colon cancer

1 reference

12 December 2020

Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility

1 reference

12 December 2020

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

1 reference

12 December 2020

Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.

1 reference

12 December 2020

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

1 reference

12 December 2020

CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage

1 reference

12 December 2020

Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells

1 reference

12 December 2020

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor

1 reference

12 December 2020

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples

1 reference

12 December 2020

FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions

1 reference

12 December 2020

VEGF-targeted therapy: mechanisms of anti-tumour activity.

1 reference

12 December 2020

Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts

1 reference

12 December 2020

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma

1 reference

12 December 2020

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

1 reference

12 December 2020

Preclinical characterization of SGN-70, a humanized antibody directed against CD70

1 reference

12 December 2020

Genome-wide analysis of cancer/testis gene expression

1 reference

12 December 2020

Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.

1 reference

12 December 2020

Optical imaging of cellular immunotherapy against prostate cancer

1 reference

12 December 2020

Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease

1 reference

12 December 2020

Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer

1 reference

12 December 2020

Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology

1 reference

12 December 2020

Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model

1 reference

12 December 2020

Glypican-3 protein expression in primary and metastatic melanoma: a combined immunohistochemistry and immunocytochemistry study

1 reference

12 December 2020

Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer

1 reference

12 December 2020

A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma

1 reference

12 December 2020

Eph receptors and ephrins in cancer: bidirectional signalling and beyond

1 reference

12 December 2020

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

12 December 2020

Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75

1 reference

12 December 2020

EpCAM in carcinogenesis: the good, the bad or the ugly

1 reference

12 December 2020

Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen

1 reference

12 December 2020

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

1 reference

12 December 2020

A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients

1 reference

12 December 2020

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

1 reference

12 December 2020

T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies

1 reference

12 December 2020

Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients.

1 reference

12 December 2020

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review

1 reference

12 December 2020

Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.

1 reference

12 December 2020

High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation

1 reference

12 December 2020

CD38 through the life of a murine B lymphocyte

1 reference

12 December 2020

A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity

1 reference

12 December 2020

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

1 reference

12 December 2020

Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma

1 reference

12 December 2020

Serum biomarker panels for the diagnosis of gastric adenocarcinoma

1 reference

12 December 2020

Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors

1 reference

12 December 2020

Advances in biomarker research for pancreatic cancer

1 reference

12 December 2020

CD70 expression patterns in renal cell carcinoma

1 reference

12 December 2020

ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth

1 reference

12 December 2020

Mesothelin, a novel immunotherapy target for triple negative breast cancer

1 reference

12 December 2020

Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.

1 reference

12 December 2020

Molecular characterization of a fully human chimeric T-cell antigen receptor for tumor-associated antigen EpCAM.

1 reference

12 December 2020

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer

1 reference

12 December 2020

The onco-embryonic antigen ROR1 is expressed by a variety of human cancers

1 reference

12 December 2020

T cells redirected to EphA2 for the immunotherapy of glioblastoma

1 reference

12 December 2020

Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms

1 reference

12 December 2020

Prostate stem cell antigen gene is expressed in islets of pancreas

1 reference

12 December 2020

B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma

1 reference

12 December 2020

Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

1 reference

12 December 2020

EpCAM: structure and function in health and disease

1 reference

12 December 2020

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma

1 reference

12 December 2020

Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia

1 reference

12 December 2020

Targeted inhibition of VEGF receptor 2: an update on ramucirumab

1 reference

12 December 2020

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy

1 reference

12 December 2020

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

1 reference

12 December 2020

PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma

1 reference

12 December 2020

T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.

1 reference

12 December 2020

A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer

1 reference

12 December 2020

Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer

1 reference

12 December 2020

Tumor-associated antigens for specific immunotherapy of prostate cancer

1 reference

12 December 2020

Kinetics of tumor destruction by chimeric antigen receptor-modified T cells

1 reference

12 December 2020

Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung

1 reference

12 December 2020

T cell responses: naive to memory and everything in between

1 reference

12 December 2020

Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy

1 reference

12 December 2020

Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma

1 reference

12 December 2020

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice

1 reference

12 December 2020

Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo.

1 reference

12 December 2020

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

1 reference

12 December 2020

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells

1 reference

12 December 2020

SSX2-4 expression in early-stage non-small cell lung cancer

1 reference

12 December 2020

A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer.

1 reference

12 December 2020

Roles of EphA2 in Development and Disease

1 reference

12 December 2020

ROR1, an embryonic protein with an emerging role in cancer biology

1 reference

12 December 2020

Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy

1 reference

12 December 2020

Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity

1 reference

12 December 2020

Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts

1 reference

12 December 2020

The Expression Pattern of CD33 Antigen Can Differentiate Leukemic from Normal Progenitor Cells in Acute Myeloid Leukemia

1 reference

12 December 2020

T cells redirected to interleukin-13Rα2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1

1 reference

12 December 2020

A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma

1 reference

12 December 2020

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

1 reference

12 December 2020

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

1 reference

12 December 2020

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy

1 reference

12 December 2020

CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?

1 reference

12 December 2020

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

1 reference

12 December 2020

Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme

1 reference

12 December 2020

Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study

1 reference

12 December 2020

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

1 reference

12 December 2020

Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

1 reference

12 December 2020

CD70: A Potential Target in Breast Cancer?

1 reference

12 December 2020

Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

1 reference

12 December 2020

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

1 reference

12 December 2020

HER2 expression status in diverse cancers: review of results from 37,992 patients

1 reference

12 December 2020

Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice

1 reference

12 December 2020

Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).

1 reference

12 December 2020

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

1 reference

12 December 2020

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T

1 reference

12 December 2020

Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

1 reference

12 December 2020

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

1 reference

12 December 2020

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

1 reference

12 December 2020

Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma

1 reference

12 December 2020

T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice

1 reference

12 December 2020

A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies

1 reference

12 December 2020

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.

1 reference

12 December 2020

Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.

1 reference

12 December 2020

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

1 reference

12 December 2020

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

1 reference

12 December 2020

CD70: An emerging target in cancer immunotherapy

1 reference

12 December 2020

Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma.

1 reference

12 December 2020

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

1 reference

12 December 2020

Targeting B-cell maturation antigen in multiple myeloma

1 reference

12 December 2020

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

1 reference

12 December 2020

Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.

1 reference

12 December 2020

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion

1 reference

12 December 2020

Classic tumor markers in gastric cancer. Current standards and limitations

1 reference

12 December 2020

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin

1 reference

12 December 2020

miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer

1 reference

12 December 2020

Expression of stem cell markers nanog and PSCA in gastric cancer and its significance

1 reference

12 December 2020

Expression of ROR1 has prognostic significance in triple negative breast cancer.

1 reference

12 December 2020

Therapeutic targeting of CD70 and CD27.

1 reference

12 December 2020

Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma

1 reference

12 December 2020

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

1 reference

12 December 2020

Chimeric antigen receptor T-cell therapy for solid tumors

1 reference

12 December 2020

HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway

1 reference

12 December 2020

Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response

1 reference

12 December 2020

T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

1 reference

12 December 2020

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

1 reference

12 December 2020

EGFRvIII: the promiscuous mutation

1 reference

12 December 2020

Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers

1 reference

12 December 2020

Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors

1 reference

12 December 2020

EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance.

1 reference

12 December 2020

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

1 reference

12 December 2020

Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.

1 reference

12 December 2020

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome.

1 reference

12 December 2020

Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies

1 reference

12 December 2020

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma

1 reference

12 December 2020

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells.

1 reference

12 December 2020

Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.

1 reference

12 December 2020

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

1 reference

12 December 2020

Mesothelin Immunotherapy for Cancer: Ready for Prime Time?

1 reference

12 December 2020

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

1 reference

12 December 2020

A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy

1 reference

12 December 2020

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.

1 reference

12 December 2020

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.

1 reference

12 December 2020

The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.

1 reference

12 December 2020

Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis

1 reference

12 December 2020

Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.

1 reference

12 December 2020

A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.

1 reference

12 December 2020

Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma

1 reference

12 December 2020

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells

1 reference

12 December 2020

Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma

1 reference

12 December 2020

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer

1 reference

12 December 2020

Chimeric antigen receptor-engineered T cells for liver cancers, progress and obstacles

1 reference

12 December 2020

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".

1 reference

12 December 2020

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

1 reference

12 December 2020

Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane.

1 reference

12 December 2020

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

1 reference

12 December 2020

ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer

1 reference

12 December 2020

Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three Cancers

1 reference

12 December 2020

A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines

1 reference

12 December 2020

Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers

1 reference

12 December 2020

T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells

1 reference

12 December 2020

Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.

1 reference

12 December 2020

CD70, a novel target of CAR T-cell therapy for gliomas.

1 reference

12 December 2020

Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers.

1 reference

12 December 2020

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

1 reference

12 December 2020

An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors

1 reference

12 December 2020

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia

1 reference

12 December 2020

Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia

1 reference

12 December 2020

A compound chimeric antigen receptor strategy for targeting multiple myeloma.

1 reference

12 December 2020

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer

1 reference

12 December 2020

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.

1 reference

12 December 2020

Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain.

1 reference

12 December 2020

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies.

1 reference

12 December 2020

Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer

1 reference

12 December 2020

High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model

1 reference

12 December 2020

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer

1 reference

12 December 2020

New Chimeric Antigen Receptor Design for Solid Tumors.

1 reference

12 December 2020

Antitumor effects and persistence of a novel HER2 CAR T cells directed to gastric cancer in preclinical models.

1 reference

12 December 2020

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer.

1 reference

12 December 2020

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma.

1 reference

12 December 2020

Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells.

1 reference

12 December 2020

A review of HPRT and its emerging role in cancer

1 reference

12 December 2020

10.1186/S13046-018-0817-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30031396%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

PubMed publication ID

30031396

1 reference